These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7534630)

  • 1. Cervical cancer.
    Beral V; Hermon C; Muñoz N; Devesa SS
    Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in cervical cancer mortality in the Americas.
    Robles SC; White F; Peruga A
    Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer in developing countries.
    Parkin DM
    Cancer Surv; 1994; 19-20():519-61. PubMed ID: 7534640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
    Simonella L; Canfell K
    Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
    Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global trends in breast cancer incidence and mortality 1973-1997.
    Althuis MD; Dozier JM; Anderson WF; Devesa SS; Brinton LA
    Int J Epidemiol; 2005 Apr; 34(2):405-12. PubMed ID: 15737977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of cancer of the cervix: global and national perspective.
    Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
    J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma.
    Cuzick J
    Cancer Surv; 1994; 19-20():455-74. PubMed ID: 7534637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union.
    Nicula FA; Anttila A; Neamtiu L; Zakelj MP; Tachezy R; Chil A; Grce M; Kesić V
    Eur J Cancer; 2009 Oct; 45(15):2679-84. PubMed ID: 19699083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer.
    Ursin G; Bernstein L; Pike MC
    Cancer Surv; 1994; 19-20():241-64. PubMed ID: 7534629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.